Business Wire

CA-LIGHTBITS-LABS

9.12.2020 14:02:15 CET | Business Wire | Press release

Share
Lightbits Expand Scale Out Disaggregated Storage Capabilities for Private, Hybrid, and Edge Deployments

Lightbits Labs today announced advancements to its cloud-native storage solution, enabling customers to confidently scale their private, hybrid, and edge cloud deployments. Lightbits, recently backed by Intel Capital , has extended its solution’s capabilities with the delivery of LightOS™ 2.1. This release further enhances high-performance, scalability, and low latency. Today’s news underpins the Lightbits vision of enabling organizations to unleash hyperscale storage for private clouds, but at a fraction of the cost of even the most advanced cloud storage offerings. LightOS 2.1 further enhances QoS for logical volumes during drive failure recoveries, multi-tenancy capabilities and adds directed-availability of snapshots and thin clones.

The new age of 5G, IoT, AI and ML and ever-increasing analytic data, calls for cloud-optimized block storage volumes that support higher IOPS, higher bandwidth and sub-millisecond, low-variance I/O latency. Like the Amazon EBS io2 Block Express volumes , which was recently announced at the AWS Re:Invent conference, Lightbits Labs’ LightOS provides high-performance, low-latency block storage volumes for on-prem cloud native application environments.

“Lightbits realized early on that disaggregated, high-performance software defined storage that utilized standard Ethernet networking is what would drive successful on-premises cloud deployments,” said Avigdor Willenz, co-founder and chairman of Lightbits Labs and previously co-founder of Annapurna Labs, acquired by Amazon in 2015. “The new Amazon EBS io2 Block Express volumes utilize scalable reliable datagrams that are implemented using custom-built, dedicated hardware. We specifically developed LightOS and NVMe/TCP to avoid the need for special network hardware yet provide a level of performance similar to local NVMe.”

As AWS extends its infrastructure offerings to hybrid cloud with its Outpost offerings, it’s clear that the future of scalable infrastructure is in native cloud practices regardless of where cloud is deployed. For private, hybrid and edge cloud deployments, Lightbits’ LightOS delivers the same or better performance than the latest Amazon EBS io2 Block Express volumes at lower cost. “This enables us to bring high-performance infrastructure for all data centers with our key Intel product portfolio,” said Remi El-Ouazzane, Vice President and Data Platforms Group Chief Strategy and Business Development Officer at Intel. “Given our recent partnership with Lightbits, we’ve had strong customer momentum in the space of disaggregated storage over TCP with customers deploying the solution in production on bare metal edge, enterprise private cloud (financial), and multi-tenancy Kubernetes-based environment for cloud service providers.”

LightOS scale out disaggregated storage solution is perfect for the largest, most performance-sensitive cloud native applications with improved price-performance, ease-of-implementation, availability and scalability. Further, as AWS is now announcing with EBS Gp3 volumes, LightOS has always decoupled IOPS from storage capacity and allowed for independent scaling of storage and compute. When combining this level of performance and flexibility along with other standard features such as thin provisioning, compression, snapshots and thin clones and the ability to utilize and extend the endurance of any flash, including QLC SSDs, it delivers EBS-like “Hyperscale Storage for All” for enterprise private clouds.

Intel’s Remi El-Ouazzane further states: “Our work with Lightbits to optimize the joint solution around Intel® Xeon® Scalable Processors, Optane™ Persistent Memory, 3D NAND QLC SSDs, and Intel® Ethernet 800 Series network adapters has delivered improved performance and TCO for our customer ecosystem.”

LightOS 2.1 is available immediately and offers better performance, scalability and latency than the most advanced cloud offerings for private clouds. With a fully programmatic API, and integration with Kubernetes and OpenStack, and the choice of software-only or a fully integrated and ready-to-run appliance, Lightbits Labs’ LightOS is ready to unleash the full power of private, hybrid and edge clouds for the next 10 years of cloud architecture.

Lightbits Labs Resources

About Lightbits Labs™
Lightbits Labs “Hyperscale Storage for All” delivers composable NVMe/TCP storage that enables on-premise, hybrid cloud, and cloud native environments to independently scale storage from compute thereby unleashing hyperscale flexibility while lowering cost and performing like local flash. The highly available software-defined storage maximizes utilization, helping customers maintain operational efficiency and easily scale their business.

Founded in 2016, Lightbits pioneered NVMe/TCP and delivered the industry’s first NVMe/TCP storage solution. Lightbits is backed by strategic investors including Intel Capital, Dell Technologies Capital, Cisco Investments, and Micron, as well as top investors and VCs including Avigdor Willenz, Lip-Bu Tan, Marius Nacht, SquarePeg Capital, and WRVI Capital. Learn more at www.lightbitslabs.com or contact us at info@lightbitslabs.com .

Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE03428.2.2026 01:00:00 CET | Press release

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG inhibitor IDE161. IDEAYA has dosed the first patient in its Phase 1 trial of IDE034, initially evaluating safety, tolerability, and PK. First dosing triggers a $5 million milestone payment to Biocytogen under the companies’ option and license agreement. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the companies’ option and license agreement, first patient dosing triggers a $5 million

IQM and Real Asset Acquisition Corp. to Host Conference Call/Webcast to Discuss Proposed Transaction27.2.2026 13:00:00 CET | Press release

IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a special purpose acquisition company (“RAAQ”), announced that they will host a conference call to discuss their recently announced business combination, including certain transaction highlights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227472716/en/ IQM Radiance quantum computer As previously disclosed, on February 23, 2026, IQM and RAAQ announced they have entered into a definitive business combination agreement, which will result in IQM becoming a public company and listing American Depositary Shares on one of the two leading U.S. stock exchanges. The transaction provides funding with the aim to accelerate IQM’s technology and commercial development towards fault-tolerance quantum computing, further advancing its position as a leading p

HighRadius Launches $0 Implementation Fee, $0 Subscription Fee via Outcome Based Pricing for oCFO Software27.2.2026 12:00:00 CET | Press release

HighRadius launches Office of the CFO first Outcome Based Pricing with $0 Implementation fee and $0 Subscription until Go-Live. Customers only pay a fraction of realized gains based on P&L impact. Chapter 1: Outcome Based Pricing (OBP)Introduction of OBP: HighRadius, a provider of 190+ AI agents for Order-to-Cash, Accounts Payable, Record-to-Report, and Treasury introduces Outcome Based Pricing (OBP). Three Components of OBP: Customers pay a) $0 in Implementation fees, b) $0 in Subscription fees until Go Live, c) HighRadius earns a fraction of the actual savings realized by the client. Chapter 2: US GAAP & ASC 606 ConstraintsNot Designed for Innovation: The traditional ASC 606 model requires companies to standardize and recognize revenue based on contractual obligations. For a traditional SaaS subscription, the obligation is access to software over time. AI agents are designed to deliver quantifiable, real-time Business Outcomes that do not fit the traditional accounting framework. Cha

Kioxia Appoints Yoshihiko Kawamura as Chief Financial Officer27.2.2026 09:15:00 CET | Press release

Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced the appointment of Yoshihiko Kawamura as Chief Financial Officer (CFO), effective April 1, 2026. Mr. Kawamura brings extensive international experience to Kioxia, having held assignments at Mitsubishi Corporation’s U.S. headquarters, served as General Manager of its Chicago office, and completed a tenure at the World Bank. At Hitachi, Ltd., he held senior leadership positions, including Chief Strategy Officer (CSO), Chief Financial Officer (CFO), and Chief Risk Management Officer (CRMO), where he was instrumental in leading the company’s management reforms. Since joining Kioxia as Executive Vice President in June 2025, Mr. Kawamura has worked closely with the executive team to advance the business through strategic capital and financial planning. Following its initial public offering on the Prime Market of the Tokyo Stock Exchange in December 2024, Kioxia is entering a new phase of growth char

DNP Invests in Rapidus to Support the Establishment of Mass Production for Next-Generation Semiconductors27.2.2026 08:18:00 CET | Press release

Will accelerate the development and mass production of EUV lithography photomasks Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912) today announced that it has participated in Rapidus Corporation’s funding round as one of the round investors. This strategic funding initiative supports Rapidus’ plan to steadily progress from its current R&D phase to mass production of 2nm (10⁻⁹ meters) logic semiconductors by 2027. Through this initiative, DNP will advance the development and mass production of EUV lithography photomasks and support Rapidus as it establishes a mass production system for 2nm & next-generation semiconductors. Background In recent years, the rise in energy consumption, in line with increased data generation, has become a challenge, driving demand for next-generation semiconductors capable of improving device performance and reducing power consumption. Next-generation semiconductors manufactured using EUV lithography enable the formation of finer patterns on silicon wafers co

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye